As efforts to control health care costs intensify, alternate sites of care are playing a larger role in optimizing the delivery of services. This care migration coupled with a robust pipeline of novel injectable and IV-administered drugs put the home and specialty infusion therapy industry in an ideal position for substantial, prolonged growth.
It’s a prerequisite that companies looking to grow their market share in the fertile home and alternate site infusion industry reach the multi-disciplinary providers in this unique care model.
NHIA, the only national trade group serving this audience, has been deeply involved with this pioneering industry since its early days in the 1980s. Reach more than 12,000 industry professionals through key NHIA member communication channels.
Advertise with us today! Contact us at advertising@nhia.org
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |